WASHINGTON REPORT BY LAURA SHELTON, CMP
MIS Data Collection
2015 Random Drug Testing Rates Announced Te minimum random drug testing rates have been announced and are effective January 1, 2015 through December 31, 2015. As a reminder, the following are the rates for other DOT modalities:
●
FAA—25 percent for drug testing, 10 percent for alcohol testing
●
FMCSA—50 percent for drug testing, 10 percent for alcohol testing
●
FR—25 percent for drug testing, 10 percent for alcohol testing
●
Most DOT Agencies and the USCG now permit (and prefer) you to submit the required drug and alcohol testing data via the internet.
● PHMSA—25 percent for drug testing
FTA—25 percent for drug testing, 10 percent for alcohol testing
How to Submit Your Required MIS DATA Collection Form Employers subject to DOT or USCG drug and alcohol testing regulations must sub- mit their annual drug and alcohol testing data as required by their respective DOT Agency or the USCG. Te annual drug and alcohol testing data being submited for a specific calendar year is to be submited by March 15 of the following calendar year. Not all DOT-regulated employers are
required to submit MIS reports, in some cases, like with FMCSA, it is required upon request only. Most DOT Agencies and the USCG
now permit (and prefer) you to submit the required drug and alcohol testing data via the Internet. If you submit the data via the Internet, you are not required to submit a hardcopy. It is recommended employers have a copy of their data available (either hard copy or in electronic format) in the event an audi- tor or inspector requests a copy. When submitting their drug and alco-
hol testing data, employers are to use the following Drug and Alcohol Testing MIS Data Collection Form and instructions. For links to instructions and to Internet
reporting visit this website: htp://www.
dot.gov/odapc/MISreporting
24 datia focus
Three Synthetic Cannabinoids Temporarily Placed as Schedule I Drugs Effective Jan. 30, 2015, the Administrator of the Drug Enforcement Administration (DEA) issued its final order to temporar- ily schedule three synthetic cannabinoids (SCs) into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act (CSA). Te substances are:
1. N-(1-amino-3-methyl-1- oxobutan-2- yl)-1-(cyclohexylmethyl)- 1H-indazole- 3-carboxamide (‘‘AB– CHMINACA’’);
2. N-(1-amino-3-methyl- 1-oxobutan- 2-yl)-1-pentyl-1H-indazole- 3-carbox- amide (‘‘AB–PINACA’’); and
3. [1-(5-fluoropentyl)-1H-indazol-3- yl](naphthalen-1-yl)methanone (‘‘THJ–2201’’).
Tis action is based on a finding by the
Administrator that the placement of these synthetic cannabinoids and their optical, positional, and geometric isomers, salts, and salts of isomers into schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanc- tions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, import, export, engage in research, or possess), or propose to handle these SCs. For more information, contact Imelda L.
Paredes, Office of Diversion Control, Drug Enforcement Administration; Mailing Ad- dress: 8701 Morrissete Drive, Springfield, Virginia 22152; Telephone: (202) 598–6812. Read the Jan. 30, 2015 Federal Register for more information.
Use of eCCF Approved by DOT Published on April 13, 2015 and effec- tive April 13, 2015, the Department of Transportation (DOT) approved the use
spring 2015
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76